BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Vaccines

ILiAD Biotechnologies Selects Emmes Group for Global Phase III Trials of BPZE1 Pertussis Vaccine

Multiple Phase III studies are expected to be conducted across North America, Central and South America, UK and other global clinical sites VaxTrials, p...

June 25, 2024 | News

FDA Approves GSK's AREXVY Vaccine for High-Risk Adults Aged 50-59

Over 13 million US adults aged 50-59 years have a medical condition that increases their risk of severe RSV outcomes1 Clinical development program conti...

June 10, 2024 | News

Thermo Fisher Scientific Opens Cutting-Edge Ultra-Cold Facility in EU to Boost Advanced Therapy Development

Thermo Fisher Scientific Inc., the world leader in serving science, has opened a new clinical and commercial ultra-cold facility in the EU, expanding its c...

June 03, 2024 | News

Serum Institute of India Acquires 20% Stake in IntegriMedical to Accelerate Development of Needle-Free Injection Technology

- With this investment, SII will acquire 20% stake in IntegriMedical - ...

May 20, 2024 | News

Overcoming Vaccine Access Challenges in Asia Pacific: Perspectives from DKSH's Reuben Ong

Timely access to vaccines is crucial for public health, especially in regions with diverse regulatory landscapes like the Asia Pacific. Bio...

May 17, 2024 | Interview

HSA Approves Arexvy, World's First RSV Vaccine, for Older Adults in Singapore

The Health Sciences Authority (HSA) of Singapore has approved Arexvy (recombinant, AS01E adjuvanted) for active immunisation to prevent lower respiratory t...

May 16, 2024 | News

WestGene Achieves FDA Approval for World's First EB Virus-Related mRNA Cancer Vaccine, WGc-043

WestGene, a biotech company dedicated to mRNA technology, announces a historic milestone with the FDA IND approval of its mRNA therapeutic cancer vaccine, ...

May 13, 2024 | News

Pfizer's Innovative Single-Dose Bivalent RSV Vaccine Approved in Hong Kong and Macau

The first and only bivalent, single-dose vaccine that fights against both RSV A and RSV B disease through two seasons has been approved by Hong K...

May 09, 2024 | News

GHIT Fund Allocates JPY 1.64 Billion to Combat Malaria and Neglected Tropical Diseases Through Innovative Partnerships

The Global Health Innovative Technology (GHIT) Fund announced a substantial investment of approximately JPY 1.64 billion (USD 10.8 million) dedicated...

May 09, 2024 | News

Infinitopes Raises £12.8M to Expand Precision Immunomics™ for Five Additional Cancers

- Infinitopes Precision Immunomics, an integrated cancer biotech combining world leading platforms in precision antigen disco...

May 01, 2024 | News

GSK Leads Adult Immunization Efforts in Malaysia for a Healthier Aging Population

As Malaysia's population shifts towards an ageing demographic, the importance of adult immunisation becomes increasingly apparent. By ensuring that individ...

April 26, 2024 | News

YS Biopharma's New HBV Vaccine Gains Clinical Trial Approval in the Philippines

YS Biopharma, a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therap...

April 19, 2024 | News

AHF Denounces Moderna’s Backtracking on African mRNA Factory as a Blow to Global Health Equity

In a scathing rebuke, the AIDS Healthcare Foundation (AHF) has criticized Moderna for suspending its plans to build a state-of-the-art mRNA manufacturing f...

April 15, 2024 | News

YS Biopharma Reports Positive Phase 3 Results for Its PIKA Rabies Vaccine

YS Biopharma Co., Ltd. (Nasdaq: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturi...

April 10, 2024 | News

Stay Connected